Subsequently, a nomogram model was developed based on IRF9, PLA2G4A, MLKL, BAX, JAK2, and STAT3 to predict the prevalence of MDS patients and the decisions benefited the MDS. The gene discussed is PLA2G4A; the disease is myelodysplastic syndrome.